Mouse Models of Human Cancer

Organizer(s): Allan Balmain and Tyler Jacks

Sponsored by Novartis Pharmaceuticals Corporation

Summary of Meeting:

The main theme of the meeting will be the exploration, using the best mouse models of the major human cancers, of questions related to the target cells for tumor development, the genetic basis to tumor susceptibility, sequential somatic genetic changes during tumor initiation promotion and progression, comparative mouse-human cancer genetics, the role of stromal/accessory cells, the immune response and cancer, and approaches to early detection using imaging or surrogate markers. A major objective will be to emphasize the parallels between mouse models and human cancers, and the advantages of these models to address questions related not only to the basic biology, but also to more practical aspects of gene discovery and therapy. Two of the sessions will be on the functions of stromal/endothelial/immune cells in cancer development to explore non-cell autonomous effects in tumor growth.

Discounted Abstract Deadline: October 16 2003

Discounted Registration Deadline: December 24 2003

We gratefully acknowledge additional support for this conference from:

Cell Signaling Technology, Inc.

Novartis Pharmaceuticals Corporation

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations